Dow completes separation from DowDuPont
Dow has successfully completed its separation from DowDuPont, becoming a more focused and streamlined materials science company in the process.
The new company will be referred to by the brand name ‘Dow’, acknowledging its legacy while also reflecting the company-wide evolution to a materials science solutions provider. Dow is adopting a new brandline — ‘Seek Together’ — which is a call to action that highlights the value of collaboration to deliver innovation and solutions to its customers and value chains.
Dow launched on 1 April with global scale and leading positions in three consumer-driven segments: packaging, infrastructure and consumer care. The company believes it is now even better positioned to drive revenue growth and innovate for its customers, leveraging three building blocks — ethylene, propylene and silicones — to power one of the deepest chemistry sets in the industry.
“Today marks the beginning of a new and exciting chapter for Dow,” said Dow CEO Jim Fitterling on the day of the separation. “The changes we have made to Dow’s portfolio, cost structure and mindset are significant. The new Dow is a more focused and streamlined company with a clear playbook to deliver long-term earnings growth and value creation for all stakeholders.
“Team Dow is well positioned to achieve our ambition of becoming the most innovative, customer-centric, inclusive and sustainable materials science company. We have all the tools in place to innovate more quickly, to operate more productively and to invest more prudently to deliver value creating growth, higher returns and enhanced shareholder value.”
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
Virologist receives GSK Award for AI-based disease detection
Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his...
WA Govt creates Science and Technology Council
The council will offer independent advice on emerging opportunities and challenges, promoting...
Billion-dollar deal for UQ's molecular clamp vaccine tech
Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...